BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 18638695)

  • 1. From studying patient treatment to studying patient care: arriving at methodologic crossroads.
    Verhoef MJ; Leis A
    Hematol Oncol Clin North Am; 2008 Aug; 22(4):671-82, viii-ix. PubMed ID: 18638695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Challenges to complementary and alternative medical research: focal issues influencing integration into a cancer care model.
    Giordano J; Engebretson J; Garcia MK
    Integr Cancer Ther; 2005 Sep; 4(3):210-8. PubMed ID: 16113028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A whole systems research approach to cancer care: why do we need it and how do we get started?
    Verhoef MJ; Vanderheyden LC; Fønnebø V
    Integr Cancer Ther; 2006 Dec; 5(4):287-92. PubMed ID: 17101757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative oncology in North America.
    Sagar SM
    J Soc Integr Oncol; 2006; 4(1):27-39. PubMed ID: 16737670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary and alternative medicine: the role of the cancer center.
    Antman K; Benson MC; Chabot J; Cobrinik D; Grann VR; Jacobson JS; Joe AK; Katz AE; Kelly K; Neugut AI; Russo D; Tiersten A; Weinstein IB
    J Clin Oncol; 2001 Sep; 19(18 Suppl):55S-60S. PubMed ID: 11560974
    [No Abstract]   [Full Text] [Related]  

  • 6. Evidence-based complementary oncology: innovative approaches to optimise standard therapy strategies.
    Beuth J
    Anticancer Res; 2010 May; 30(5):1767-71. PubMed ID: 20592376
    [TBL] [Abstract][Full Text] [Related]  

  • 7. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reflections on ethical concerns arising from the incorporation of results of randomized trials of antineoplastic therapy into routine clinical practice.
    Markman M
    Cancer Invest; 2005; 23(8):735-40. PubMed ID: 16377592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethical issues in integrative oncology.
    Ben-Arye E; Schiff E; Golan O
    Hematol Oncol Clin North Am; 2008 Aug; 22(4):737-53, x. PubMed ID: 18638699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporating complementary and integrative medicine in a comprehensive cancer center.
    Frenkel M; Cohen L
    Hematol Oncol Clin North Am; 2008 Aug; 22(4):727-36, ix. PubMed ID: 18638698
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to improve communication between physicians and cancer patients about use of complementary and alternative medicine?
    Söllner W; Maislinger S; Kappauf H
    Psychooncology; 2003 Mar; 12(2):203-4. PubMed ID: 12619152
    [No Abstract]   [Full Text] [Related]  

  • 12. [Patient-oriented, treatment-accompanying documentation as a basis for evaluation with medical oncology as an example].
    Hölzer S; Wächter W; Dudeck J
    Z Arztl Fortbild Qualitatssich; 2000 Oct; 94(9):759-64. PubMed ID: 11127784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proposal for an integrated evaluation model for the study of whole systems health care in cancer.
    Jonas WB; Beckner W; Coulter I
    Integr Cancer Ther; 2006 Dec; 5(4):315-9. PubMed ID: 17101760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative medicine and patient-centered care.
    Maizes V; Rakel D; Niemiec C
    Explore (NY); 2009; 5(5):277-89. PubMed ID: 19733814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between academic oncology and alternative/complementary/integrative medicine: complex but necessary.
    Markman M
    J Clin Oncol; 2001 Sep; 19(18 Suppl):52S-53S. PubMed ID: 11560972
    [No Abstract]   [Full Text] [Related]  

  • 16. Review. Evidence-based complementary oncology. Innovative approaches to optimize standard therapy strategies.
    Beuth J; Schierholz JM
    In Vivo; 2007; 21(2):423-8. PubMed ID: 17436598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative cancer cures.
    Ernst E
    Br J Cancer; 2001 Sep; 85(5):781-2. PubMed ID: 11531268
    [No Abstract]   [Full Text] [Related]  

  • 18. The challenges of randomized trials in integrative cancer care.
    Block KI; Cohen AJ; Dobs AS; Ornish D; Tripathy D
    Integr Cancer Ther; 2004 Jun; 3(2):112-27. PubMed ID: 15165498
    [No Abstract]   [Full Text] [Related]  

  • 19. Perceptions and attitudes of clinical oncologists on complementary and alternative medicine: a nationwide survey in Japan.
    Bernardi D; Giacalone A; Tirelli U
    Cancer; 2003 Nov; 98(10):2302-3; author reply 2303. PubMed ID: 14601102
    [No Abstract]   [Full Text] [Related]  

  • 20. Translating clinical trials into meaningful outcomes.
    LoRusso PM; Schnipper LE; Stewart DJ; Boerner SA; Averbuch SD; Wolf W
    Clin Cancer Res; 2010 Dec; 16(24):5951-5. PubMed ID: 21169247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.